C34H52O9
Neat
604.78
Spinosyn D 17-pseudoaglycone; 131929-55-0; (1S, 2S, 5R, 7S, 9S, 10S, 14R, 15S, 19S)-19-Ethyl-15-hydroxy-4, 14-dimethyl-7-[(2R, 3R, 4R, 5S, 6S)-3, 4, 5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02, 10.05, 9]docosa-3, 11-diene-13, 21-dione; A 83543D pseudoaglycone; A83543D pseudoaglycone; A-83543D pseudoaglycone; Spinosyn D17- pseudoaglycone; W3729CYR4M; DTXSID301343056; C34H52O9; (1S, 2S, 5R, 7S, 9S, 10S, 14R, 15S, 19S)-19-ethyl-15-hydroxy-4, 14-dimethyl-7-[(2R, 3R, 4R, 5S, 6S)-3, 4, 5-trimethoxy-6-methyl-tetrahydropyran-2-yl]oxy-20-oxatetracyclo[10.10.0.02, 10.05, 9]docosa-3, 11-diene-13, 21-dione; (2S, 3aR, 5aS, 5bS, 9S, 13S, 14R, 16aS, 16bS)-2-[(6-Deoxy-2, 3, 4-tri-O-methyl-alpha-L-mannopyranosyl)oxy]-9-ethyl-2, 3, 3a, 5a, 5b, 6, 9, 10, 11, 12, 13, 14, 16a, 16b-tetradecahydro-13-hydroxy-4, 14-dimethyl-1H-as-indaceno[3, 2-d]oxacyclododecin-7, 15-dione; 1H-as-Indaceno[3, 2-d]oxacyclododecin-7, 15-dione, 2-[(6-deoxy-2, 3, 4-tri-O-methyl-alpha-L-mannopyranosyl)oxy]-9-ethyl-2, 3, 3a, 5a, 5b, 6, 9, 10, 11, 12, 13, 14, 16a, 16b-tetradecahydro-13-hydroxy-4, 14-dimethyl-, (2S, 3aR, 5aS, 5bS, 9S, 13S, 14R, 16aS and 16bS)-
(1S, 2S, 5R, 7S, 9S, 10S, 14R, 15S, 19S)-19-ethyl-15-hydroxy-4, 14-dimethyl-7-[(2R, 3R, 4R, 5S, 6S)-3, 4, 5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02, 10.05, 9]docosa-3, 11-diene-13 and 21-dione
InChI=1S/C34H52O9/c1-8-20-10-9-11-28(35)18(3)30(37)27-15-25-23(26(27)16-29(36)42-20)12-17(2)22-13-21(14-24(22)25)43-34-33(40-7)32(39-6)31(38-5)19(4)41-34/h12,15,18-26,28,31-35H,8-11,13-14,16H2,1-7H3/t18-,19+,20+,21-,22+,23-,24-,25-,26+,28+,31+,32-,33-,34+/m1/s1